Current Drug Targets

Editor-in-Chief:

Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

Back

Become EABM
Become Reviewer

Editorial [Hot Topic:Strategies for Molecular-Based Treatment of Hematological Malignancies (Guest Editor: Per Ole Iversen)] promotion: free to download

Volume:6   Issue:6
Pp: 629-629
Per O. Iversen
DOI: 10.2174/1389450054863680

Proteomics in Acute Myelogenous Leukaemia (AML): Methodological Strategies and Identification of Protein Targets for Novel Antileukaemic Therapy

Volume:6   Issue:6
Pp: 631-646
G. Sjoholt, N. Anensen, L. Wergeland, E. Mc Cormack, O. Bruserud and B. T. Gjertsen
DOI: 10.2174/1389450054863671

Ribozymes, DNAzymes and Small Interfering RNAs as Therapeutics

Volume:6   Issue:6
Pp: 647-653
M. Sioud and P. O. Iversen
DOI: 10.2174/1389450054863653

Protein Kinase A (PKA) - A Potential Target for Therapeutic Intervention of Dysfunctional Immune Cells

Volume:6   Issue:6
Pp: 655-664
B. S. Skalhegg, A. Funderud, H. H. Henanger, T. T. Hafte, A. C. Larsen, A.- K. Kvissel, S. Eikvar and S. Orstavik
DOI: 10.2174/1389450054863644

Angiogenesis and Hemostasis in Hematological Neoplasias

Volume:6   Issue:6
Pp: 683-699
H. Negaard, A. Dahm, P. M. Sandset, P. O. Iversen and B. Ostenstad
DOI: 10.2174/1389450054863699

Identification of New Targets for Therapy of Osteolytic Bone Disease in Multiple Myeloma

Volume:6   Issue:6
Pp: 701-711
O. Hjertner, T. Standal, M. Borset, A. Sundan and A. Waage
DOI: 10.2174/1389450054863716